Does ADALIMUMAB Cause Exposure to sars-cov-2? 182 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 182 reports of Exposure to sars-cov-2 have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
182
Reports of Exposure to sars-cov-2 with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
6
Deaths
46
Hospitalizations
How Dangerous Is Exposure to sars-cov-2 From ADALIMUMAB?
Of the 182 reports, 6 (3.3%) resulted in death, 46 (25.3%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Exposure to sars-cov-2 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 182 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Exposure to sars-cov-2?
INFLIXIMAB (201)
INFLIXIMAB-DYYB (143)
CERTOLIZUMAB PEGOL (89)
DUPILUMAB (78)
TOFACITINIB (66)
RITUXIMAB (49)
ETEPLIRSEN (36)
PREDNISONE (35)
ETANERCEPT (33)
SECUKINUMAB (33)
Which ADALIMUMAB Alternatives Have Lower Exposure to sars-cov-2 Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB